Return On Equity of Moleculin Biotech, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Moleculin Biotech, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Moleculin Biotech, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 3735%.
  • Moleculin Biotech, Inc. annual Return On Equity for 2024 was -119%, a 52% decline from 2023.
  • Moleculin Biotech, Inc. annual Return On Equity for 2023 was -78%, a 68% decline from 2022.
  • Moleculin Biotech, Inc. annual Return On Equity for 2022 was -47%, a 144% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Moleculin Biotech, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 3735% +3863% 01 Jul 2025 30 Sep 2025
Q2 2025 -340% -238% -232% 01 Apr 2025 30 Jun 2025
Q1 2025 -137% -51% -60% 01 Jan 2025 31 Mar 2025
Q4 2024 -119% -41% -52% 01 Oct 2024 31 Dec 2024
Q3 2024 -128% -68% -111% 01 Jul 2024 30 Sep 2024
Q2 2024 -103% -43% -72% 01 Apr 2024 30 Jun 2024
Q1 2024 -86% -32% -59% 01 Jan 2024 31 Mar 2024
Q4 2023 -78% -32% -68% 01 Oct 2023 31 Dec 2023
Q3 2023 -61% -24% -67% 01 Jul 2023 30 Sep 2023
Q2 2023 -60% -32% -114% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% -31% -134% 01 Jan 2023 31 Mar 2023
Q4 2022 -47% -27% -144% 01 Oct 2022 31 Dec 2022
Q3 2022 -36% -13% -57% 01 Jul 2022 30 Sep 2022
Q2 2022 -28% +0.8% +2.8% 01 Apr 2022 30 Jun 2022
Q1 2022 -23% +37% +62% 01 Jan 2022 31 Mar 2022
Q4 2021 -19% +91% +83% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% +98% +81% 01 Jul 2021 30 Sep 2021
Q2 2021 -29% +89% +76% 01 Apr 2021 30 Jun 2021
Q1 2021 -60% -2.7% -4.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -110% -36% -48% 01 Oct 2020 31 Dec 2020
Q3 2020 -121% -52% -74% 01 Jul 2020 30 Sep 2020
Q2 2020 -118% -57% -93% 01 Apr 2020 30 Jun 2020
Q1 2020 -58% +35% +37% 01 Jan 2020 31 Mar 2020
Q4 2019 -74% -2.7% -3.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% +1.1% +1.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -61% +11% +15% 01 Apr 2019 30 Jun 2019
Q1 2019 -92% -32% -53% 01 Jan 2019 31 Mar 2019
Q4 2018 -71% -16% -30% 01 Oct 2018 31 Dec 2018
Q3 2018 -71% -24% -52% 01 Jul 2018 30 Sep 2018
Q2 2018 -72% -32% -81% 01 Apr 2018 30 Jun 2018
Q1 2018 -60% -36% -149% 01 Jan 2018 31 Mar 2018
Q4 2017 -55% -22% -68% 01 Oct 2017 31 Dec 2017
Q3 2017 -47% 01 Jul 2017 30 Sep 2017
Q2 2017 -40% 01 Apr 2017 30 Jun 2017
Q1 2017 -24% 01 Jan 2017 31 Mar 2017
Q4 2016 -33% 01 Oct 2016 31 Dec 2016

Moleculin Biotech, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -119% -41% -52% 01 Jan 2024 31 Dec 2024
2023 -78% -32% -68% 01 Jan 2023 31 Dec 2023
2022 -47% -27% -144% 01 Jan 2022 31 Dec 2022
2021 -19% +91% +83% 01 Jan 2021 31 Dec 2021
2020 -110% -36% -48% 01 Jan 2020 31 Dec 2020
2019 -74% -2.7% -3.8% 01 Jan 2019 31 Dec 2019
2018 -71% -16% -30% 01 Jan 2018 31 Dec 2018
2017 -55% -22% -68% 01 Jan 2017 31 Dec 2017
2016 -33% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.